WXWeipeng Xu

Weipeng Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Weipeng Xu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association between gestational diabetes mellitus and maternal and neonatal outcomes in twin pregnancies: a retrospective cohort study in Guangdong, China

    by Liting Huang, Weipeng Xu, Wei Li, Ya Jin, Sui Zhu, Guosheng Liu, Chuan Nie, Yueqin Ding, Bingxiao Li, Shasha Han

    Background In singleton pregnancies, gestational diabetes mellitus (GDM) causes maternal and neonatal complications. However, this association remains unclear in twin pregnancies. This study aimed to investigate the association between GDM and obstetric outcomes specifically in twin pregnancies. Methods A retrospective cohort study was conducted among women with twin pregnancies from January 2018 to July 2022. Maternal and neonatal outcomes were compared between women with and without GDM. Adjusted ORs, 95% CIs and SEs were estimated using logistic regression, adjusting for maternal age, prepregnancy body mass index and chorionicity. Results A total of 808 women (1616 neonates) were included in the study, of whom 178 had GDM, while 630 did not. GDM was found to be positively associated with (adjusted OR, (95% CI)) preterm birth (1.73 (1.17 to 2.54)), premature rupture of membranes (1.70 (1.03 to 2.79)) and hypothyroidism (2.58 (1.46 to 4.56)) in women with twin pregnancies. In regard to neonatal outcomes, GDM was positively associated with admission to neonatal ward (1.49 (1.13 to 1.96)), oxygen therapy (1.91 (1.45 to 2.52)), hyperbilirubinaemia (1.44 (1.08 to 1.90)), total use and prophylactic use of antibiotics (1.98 (1.17 to 3.33) and 1.88 (1.00 to 3.54), respectively). When stratified by gestational age, GDM remained positively associated with certain adverse outcomes exclusively in twin preterm infants. Conclusions Our study demonstrated that GDM is significantly associated with several adverse pregnancy outcomes in twin pregnancies, including hypothyroidism in pregnant women, preterm birth, admission to neonatal ward, oxygen therapy, hyperbilirubinaemia, the total and prophylactic use of antibiotics in twins. Specifically, in twin pregnancies, GDM may be more strongly associated with adverse outcomes in preterm infants than in term infants.

  • Open Access

    Inhaled nitric oxide in preterm infants with respiratory disease: a systematic review and meta-analysis

    by Kai Zhou, Weipeng Xu, Danrui Li, CheokUn Lao, Shiqian Zou, Shixian Liu, Bingxiao Li, Fangfang Zeng, Sui Zhu, Shasha Han

    Background: Inhaled nitric oxide (iNO) has been shown to be effective in term and near-term infants with specific respiratory diseases. The effects and potential risks of iNO differ substantially in preterm infants with special pathophysiology. Specific study in this population is necessary. Purpose: To assess the short-term and long-term effects of iNO in preterm infants with respiratory diseases such as respiratory failure and respiratory distress syndrome. Methods: We conducted a meta-analysis of randomized controlled trials and cohort studies comparing iNO with placebo or blank control in preterm infants with respiratory diseases.Databases including PubMed, the Cochrane Library, Scopus, and Web of Science were searched from their inception until May 2025. The primary outcomes were death before discharge, death at 36 weeks’ postmenstrual age (PMA), bronchopulmonary dysplasia (BPD) and death or BPD. Results: Thirty-one trials met the inclusion criteria. iNO reduced the incidence of death or BPD (risk ratio [RR] 0.94, 95% confidence interval [CI] 0.88 to 0.99, 6 studies, 1954 infants) and BPD in the RCT subgroup (RR 0.91, 95% CI 0.84 to 0.99, 8 studies, 2196 infants).Increases of oxygenation index (Standardized mean difference (SMD) − 0.62, 95% CI − 0.81 to − 0.43, 2 studies, 441 infants) and Partial pressure of oxygen (PaO2) (SMD 0.68, 95% CI 0.49 to 0.87, 2 studies, 441 infants) of preterm infants at 5 ppm initial concentration were observed in the iNO group. The iNO group demonstrated a higher risk of retinopathy of prematurity (RR 1.08, 95% CI 1.01 to 1.16, 17 studies, 7220 infants). No significant differences were observed in other neonatal morbidities or adverse events. Conclusions: iNO was associated with a reduced risk of death or BPD and a probably reduction of BPD. There was no effect on other morbidities or adverse events. Data on long-term respiratory and neurodevelopment outcomes are critically needed to further evaluate NO's efficacy in preterm infants, particularly Extremely low birth weight infants.